Literature DB >> 2164639

bcr/abl and src but not myc and ras replace v-abl in lymphoid transformation.

A Engelman1, N Rosenberg.   

Abstract

Lymphoid cells transformed by temperature-sensitive Abelson virus die at the nonpermissive temperature. This property was exploited to show that bcr/abl and v-src but not myc and ras can replace the transforming signal of v-abl, a result suggesting that the former but not the latter oncogenes transform lymphoid cells via a similar pathway.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2164639      PMCID: PMC360988          DOI: 10.1128/mcb.10.8.4365-4369.1990

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  28 in total

1.  Amplification and altered expression of the c-myc oncogene in A-MuLV-transformed fibroblasts.

Authors:  A Nepveu; P D Fahrlander; J Q Yang; K B Marcu
Journal:  Nature       Date:  1985 Oct 3-9       Impact factor: 49.962

2.  Interaction between Raf and Myc oncogenes in transformation in vivo and in vitro.

Authors:  J L Cleveland; H W Jansen; K Bister; T N Fredrickson; H C Morse; J N Ihle; U R Rapp
Journal:  J Cell Biochem       Date:  1986       Impact factor: 4.429

3.  Coinfection with viruses carrying the v-Ha-ras and v-myc oncogenes leads to growth factor independence by an indirect mechanism.

Authors:  M Vogt; J Lesley; J Bogenberger; S Volkman; M Haas
Journal:  Mol Cell Biol       Date:  1986-10       Impact factor: 4.272

4.  Synergism of v-myc and v-Ha-ras in the in vitro neoplastic progression of murine lymphoid cells.

Authors:  R C Schwartz; L W Stanton; S C Riley; K B Marcu; O N Witte
Journal:  Mol Cell Biol       Date:  1986-09       Impact factor: 4.272

5.  Monoclonal antibodies specific for v-abl- and c-abl-encoded molecules.

Authors:  L Schiff-Maker; M C Burns; J B Konopka; S Clark; O N Witte; N Rosenberg
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

6.  Monoclonal antibodies to the p21 products of the transforming gene of Harvey murine sarcoma virus and of the cellular ras gene family.

Authors:  M E Furth; L J Davis; B Fleurdelys; E M Scolnick
Journal:  J Virol       Date:  1982-07       Impact factor: 5.103

7.  In vitro transformation of murine pre-B lymphoid cells by Snyder-Theilen feline sarcoma virus.

Authors:  J H Pierce; S A Aaronson
Journal:  J Virol       Date:  1983-06       Impact factor: 5.103

8.  Monoclonal antibodies to Rous sarcoma virus pp60src react with enzymatically active cellular pp60src of avian and mammalian origin.

Authors:  S J Parsons; D J McCarley; C M Ely; D C Benjamin; J T Parsons
Journal:  J Virol       Date:  1984-08       Impact factor: 5.103

9.  Abelson transformed fibroblasts lacking the EGF receptor are not tumourigenic in nude mice.

Authors:  A Gebhardt; J C Bell; J G Foulkes
Journal:  EMBO J       Date:  1986-09       Impact factor: 11.598

10.  Requirement for c-ras proteins during viral oncogene transformation.

Authors:  M R Smith; S J DeGudicibus; D W Stacey
Journal:  Nature       Date:  1986 Apr 10-16       Impact factor: 49.962

View more
  13 in total

1.  Gag influences transformation by Abelson murine leukemia virus and suppresses nuclear localization of the v-Abl protein.

Authors:  Chae-Ryun Yi; Naomi Rosenberg
Journal:  J Virol       Date:  2007-06-27       Impact factor: 5.103

2.  Temperature-sensitive mutants of Abelson murine leukemia virus deficient in protein tyrosine kinase activity.

Authors:  A Engelman; N Rosenberg
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

3.  The extreme carboxyl terminus of v-Abl is required for lymphoid cell transformation by Abelson virus.

Authors:  David Warren; Deborah S Griffin; Celine Mainville; Naomi Rosenberg
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

4.  Oncogenic activation of c-ABL by mutation within its last exon.

Authors:  A Goga; J McLaughlin; A M Pendergast; K Parmar; A Muller; N Rosenberg; O N Witte
Journal:  Mol Cell Biol       Date:  1993-08       Impact factor: 4.272

5.  Temperature-sensitive transformation by an Abelson virus mutant encoding an altered SH2 domain.

Authors:  C A Mainville; K Parmar; I Unnikrishnan; L Gong; G D Raffel; N Rosenberg
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

6.  Lymphoid cells transformed by Abelson virus require the v-abl protein-tyrosine kinase only during early G1.

Authors:  Y Y Chen; N Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

7.  Absence of p53 complements defects in Abelson murine leukemia virus signaling.

Authors:  Indira Unnikrishnan; Naomi Rosenberg
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

8.  Ras complements the carboxyl terminus of v-Abl protein in lymphoid transformation.

Authors:  K Parmar; N Rosenberg
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

9.  Active Akt and functional p53 modulate apoptosis in Abelson virus-transformed pre-B cells.

Authors:  Li Gong; Indira Unnikrishnan; Anuradha Raghavan; Kalindi Parmar; Naomi Rosenberg
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

10.  Lin28 promotes transformation and is associated with advanced human malignancies.

Authors:  Srinivas R Viswanathan; John T Powers; William Einhorn; Yujin Hoshida; Tony L Ng; Sara Toffanin; Maureen O'Sullivan; Jun Lu; Letha A Phillips; Victoria L Lockhart; Samar P Shah; Pradeep S Tanwar; Craig H Mermel; Rameen Beroukhim; Mohammad Azam; Jose Teixeira; Matthew Meyerson; Timothy P Hughes; Josep M Llovet; Jerald Radich; Charles G Mullighan; Todd R Golub; Poul H Sorensen; George Q Daley
Journal:  Nat Genet       Date:  2009-05-31       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.